Burrows Scott L - Insider Non-Derivative Transactions at Spyre Therapeutics, Inc. (SYRE) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Sep 3, 2024, Burrows Scott L's relationship to Spyre Therapeutics, Inc. (SYRE) is Officer (Chief Financial Officer), and currently has 116,422 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other SYRE insiders.

Data Source: SEC.
Burrows Scott L - Insider Non-Derivative Transactions of SYRE Common Stock
Burrows Scott L - Insider Non-Derivative Transactions at SYRE
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Sep 4, 2024 Sell -- (Common Stock) 18531 28.17 116422
Dec 23, 2023 Acquisition -- (Common Stock) 134953 0 134953